Skip to main navigation
Skip to search
Skip to main content
Experts@Minnesota Home
Search content at Experts@Minnesota
Home
Profiles
Research units
University Assets
Projects and Grants
Research output
Datasets
Press/Media
Activities
Fellowships, Honors, and Prizes
Impacts
Uric Acid and Long-term Outcomes in CKD
Magdalena Madero
, Mark J. Sarnak
, Xuelei Wang
, Tom Greene
, Gerald J. Beck
, John W. Kusek
, Allan J Collins
, Andrew S. Levey
, Vandana Menon
Medicine - Renal and Hypertension Division
Research output
:
Contribution to journal
›
Article
›
peer-review
376
Link opens in a new tab
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Uric Acid and Long-term Outcomes in CKD'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Chronic Kidney Disease
100%
Hazard Ratio
100%
Uric Acid
100%
95% Confidence Interval
100%
Kidney Failure
83%
Uric Acid Levels
83%
Cardiovascular Mortality
66%
Mortality Hazard
66%
All-cause Mortality
50%
Failure Hazard
33%
Hyperuricemia
33%
Patient Demographics
16%
Randomized Controlled Trial
16%
Diabetic Kidney Disease
16%
Cardiovascular Disease
16%
Cardiovascular Risk Factors
16%
Glomerular Filtration Rate
16%
Non-associated
16%
Modification of Diet in Renal Disease
16%
Multivariate Model
16%
White Patients
16%
Blood Pressure Control
16%
Single Measurement
16%
Dietary Protein Restriction
16%
Continuous Analysis
16%
Independent Risk Factors
16%
Medicine and Dentistry
Chronic Kidney Disease
100%
Uric Acid
100%
Long-Term Outcome
100%
Hazard Ratio
75%
Cardiovascular Disease
62%
Renal Failure
62%
All Cause Mortality
37%
Hyperuricemia
25%
Protein Intake
12%
Outcome Assessment
12%
Cohort Analysis
12%
Blood Pressure
12%
Nephropathy
12%
Randomized Controlled Trial
12%
Patient Population
12%
Glomerular Filtration Rate
12%
Pressure Control
12%
Protein Restriction
12%
Median Follow Up
12%
Nursing and Health Professions
Chronic Kidney Failure
100%
Uric Acid
100%
Hazard Ratio
75%
Confidence Interval
75%
Kidney Failure
62%
Cardiovascular Disease
62%
All Cause Mortality
37%
Hyperuricemia
25%
Kidney Disease
12%
Glomerulus Filtration Rate
12%
Patient Population
12%
Blood Pressure
12%
Outcome Assessment
12%
Cohort Analysis
12%
Protein Intake
12%
Pressure Control
12%
Protein Restriction
12%